Kanamycin Monosulfate
CAS Number: 25389-94-0
Formula: C18H36N4O11·H2SO4
ASSAY: 80% MIN, 95% MIN
Description: Kanamycin Monosulfate is a water-soluble salt derived from Streptomyces kanamyceticus. It belongs to the aminoglycoside class of antibiotics and is closely related to Kanamycin Acid Sulfate. It exhibits broad-spectrum antibacterial activity against Gram-negative and some Gram-positive bacteria.
Category: Antibiotic
Use: Kanamycin Monosulfate is used for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and bacterial septicemia. It is particularly effective against infections caused by strains of Klebsiella, Proteus, Pseudomonas, and Escherichia coli.
Dosage & Administration: The dosage and administration of Kanamycin Monosulfate should be determined by a healthcare professional based on factors such as the patient’s age, weight, renal function, and the severity of the infection. It is typically administered via intramuscular or intravenous injection. Dosage may vary, but a common dosage for adults is 7.5 mg/kg every 8 hours. Dosage adjustments may be necessary in patients with impaired renal function.
Package Size: Kanamycin Monosulfate is available in various package sizes, including vials or ampules containing powder for reconstitution with sterile water for injection. Typical package sizes may range from 1 gram to 20 grams, depending on the manufacturer and intended use.
CAS Number: 25389-94-0
Formula: C18H36N4O11·H2SO4
ASSAY: 80% MIN, 95% MIN
Description: Kanamycin Monosulfate is a water-soluble salt derived from Streptomyces kanamyceticus. It belongs to the aminoglycoside class of antibiotics and is closely related to Kanamycin Acid Sulfate. It exhibits broad-spectrum antibacterial activity against Gram-negative and some Gram-positive bacteria.
Category: Antibiotic
Use: Kanamycin Monosulfate is used for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and bacterial septicemia. It is particularly effective against infections caused by strains of Klebsiella, Proteus, Pseudomonas, and Escherichia coli.
Dosage & Administration: The dosage and administration of Kanamycin Monosulfate should be determined by a healthcare professional based on factors such as the patient’s age, weight, renal function, and the severity of the infection. It is typically administered via intramuscular or intravenous injection. Dosage may vary, but a common dosage for adults is 7.5 mg/kg every 8 hours. Dosage adjustments may be necessary in patients with impaired renal function.
Package Size: Kanamycin Monosulfate is available in various package sizes, including vials or ampules containing powder for reconstitution with sterile water for injection. Typical package sizes may range from 1 gram to 20 grams, depending on the manufacturer and intended use.
